Buscar resultados de ensayos clínicos
Mixed Tumor, Mullerian - 25 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: Imatinib Mesylate in Treating Patients With Recurrent or Persistent Uterine Cancer Condición:
Fecha: 2004-01-09 Intervenciones:
|
Not yet recruiting |
Nombre del estudio: microRNA Profiles Identification in Adeno Carcinoma Prostate Cancer Condición: Prostate Carcinosarcoma Fecha: 2016-11-08 Intervenciones: Biological: High PSA levels |
No longer available |
Nombre del estudio: Protocol to Allow Continued Access of Ficlatuzumab to P05538 Patient Condición: Mullerian Mixed Tumor of Ovary Fecha: 2014-03-14 Intervenciones: Drug: ficlatuzumab humanized anti-hepatocyte growth factor (HGF) monoclonal antibody IV administration a |
Completed |
Nombre del estudio: Avastin +/- Erlotinib Consolidation Chemotherapy After Carboplatin, Paclitaxel, and Avastin (CTA) Induction Therapy for Advanced Ovarian, Fallopian Tube, Primary Peritoneal Cancer & Papillary Serous or Clear Cell Mullerian Tumors Condición:
|
Recruiting |
Nombre del estudio: Suitability of DCE-MRI for Detection of Vascular Changes After VBT Condición: Carcinoma of the Cervix, Carcinoma or Carcinosarcoma of the Uterus Fecha: 2013-11-11 Intervenciones: Radiation: Radiotherapy |
Recruiting |
Nombre del estudio: A Phase I Study of Lapatinib (Tykerb) Plus Ixabepilone (Ixempra) as 2nd-line Treatment for Patients With HER-2 Overexpressed Recurrent or Persistent Endometrial Carcinoma or Carcinosarcoma Condición: Recurrent Endometrial Cancer Fecha: 2011-09-28 Intervenciones: Drug: Lapatinib and ixempra Ixabepilone 40 mg/m2 Lapatinib 250 mg |
Completed |
Nombre del estudio: Sorafenib in Treating Patients With Advanced or Recurrent Uterine Cancer Condición:
|
Terminated |
Nombre del estudio: Topotecan in Treating Patients With Recurrent or Refractory Cancer of the Uterus Condición: Sarcoma Fecha: 2000-11-06 Intervenciones: Drug: topotecan hydrochloride |
Recruiting |
Nombre del estudio: A Study of Durvalumab With or Without Tremelimumab in Endometrial Cancer Condición:
|
Completed |
Nombre del estudio: Multicenter Trial With PegLiposomal Doxorubicin and Carboplatin Combination Chemotherapy in Gynecological Sarcomas and Mixed Epithelial-Mesenchymal Tumors Condición:
|